A comparative study of the effect of Rose and Saffron herbal tea on stress, anxiety and depression

A comparative study of the effect of Rose and Saffron herbal tea on stress, anxiety and depression among Iran Chemical Industry Investment company’s employees in Isfahan in 2016.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015072613416N4

Enrollment

Registered

2016-08-11

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Stress. Condition 3: Anxiety. Depressive episode, unspecified Neurotic, stress-related and somatoform disorders Anxiety disorder, unspecified

Interventions

Intervention 1: herbal infusio of Saffron (30 mg) in 150cc water per day for 4 weeks. Intervention 2: herbal infusion of Rose (4 gr) in 150cc water per day for 4 weeks.

Treatment - Other

herbal infusio of Saffron (30 mg) in 150cc water per day for 4 weeks

herbal infusion of Rose (4 gr) in 150cc water per day for 4 weeks

Eligibility

Sex/Gender

Male

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: working in technical section of the Iran Chemical Industry Investment Company; working in a day shift; not facing everyday life stressful events such as a death, divorce and other miserable events in a year prior to the study; being interested in attending the study; having at least one year of work experience in one of the technical units of ICIIC; being exposed to industrial stressful factors (noise, environmental pollutants, tools and machinery etc); no history of cardiovascular diseases, asthma, allergy, hypertension, kidney and psychotic disorders , and taking the related medications. exclusion criteria: facing everyday life stressful events such as a death, divorce and other miserable events during the study; not being interested in attending the study; cardiovascular diseases, asthma, allergy, hypertension, kidney and psychotic disorders, and taking the related medications; every health problem that may be harmful for participants to continue intervention (after expertise council).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Stress. Timepoint: Before and after intervention. Method of measurement: DASS21 quesionnaire.;Depression. Timepoint: Before and after intervention. Method of measurement: DASS21 quesionnaire.;Anxiety. Timepoint: Before and after intervention. Method of measurement: DASS21 Quesionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayeh Gorji

Iran Chemical Industry Investment Company

s_gorji@nm.mui.ac.ir+98 31 3653 2957

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026